Siglec-15 Promotes Tumor Progression in Osteosarcoma via DUSP1/MAPK Pathway

Overview of attention for article published in Frontiers in oncology, July 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,571 followers.

Siglec-15 Promotes Tumor Progression in Osteosarcoma via DUSP1/MAPK Pathway https://t.co/FrgLTxhhAD

02 Aug 2021

Reply Repost Favourite

New research: Siglec-15 Promotes Tumor Progression in Osteosarcoma via DUSP1/MAPK Pathway: Recurrence and metastasis are important features of osteosarcoma (OS) that cause its poor prognosis. Aberrant expression of Sialic acid-binding… https://t.co/Kpej9RI

16 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.